14 FEB. 2023 · In the final episode of Breaking Down Barriers, we highlight the second part of our conversation with Dr. Sam Spigelman. In the last episode, he spoke about the critical importance of early diagnosis when effectively treating bladder cancer and provided some education that can help clinicians and patients navigate diagnosis and treatment. Hear him touch on potentially transformative advances in bladder cancer diagnosis and treatment, discuss why innovation in bladder cancer treatments has been limited and how that is changing now, and talk about genetic alterations, systemic toxicities and why avoiding bladder surgery and removal is so important.

30 ENE. 2023 · In the fourth episode of this series, Breaking Down Barriers, Dr. Sam Spigelman helps shed light on the importance of early diagnosis and treatment in bladder cancer and the innovations needed for effective therapies in early-stage bladder cancer.

2 SEP. 2022 · In Episode 3 of Breaking Down Barriers, a podcast about the people and science behind innovative bladder cancer treatments, we hear from Dr. Pat Keegan on the various forms of bladder cancer and the importance of genetic testing and improving patient outcomes.

9 MAY. 2022 · In Episode 2 of Breaking Down Barriers, a podcast about the people and science behind innovative bladder cancer treatments, we take a look at the recent research breakthroughs happening at Janssen Oncology. Hear Dr. Christopher Cutie, bladder cancer researcher and the disease area leader of bladder cancer at Janssen, discuss these breakthroughs and how they have the potential to transform bladder cancer treatment and improve the lives of patients.

11 ABR. 2022 · An interview with Dr. Christopher Cutie, a bladder cancer researcher and the disease area leader of bladder cancer at Janssen Oncology, who has helped pioneer innovative bladder cancer treatments for over a decade. In this episode, he opens up about his personal experience working with bladder cancer patients and the motivation behind dedicating his life to improving bladder cancer treatments.